糖皮质激素抑制加压素释放的细胞膜机制

利用离休孵育脑薄片和放射免疫测定其释放的精氨酸加压素（ＡＶＰ）方法,探讨糖皮质激素（ＧＣ）在不能进入细胞内的情况下,对去肾上腺大鼠的下丘脑薄片释放ＡＶＰ的快速影响及其可能的细胞膜机制。结果如下：（１）下丘脑薄片能够稳定地释放ＡＶＰ（２ｈ）,其释放量为１５．４２±１．２８ｐｇ／ｍｉｎ;（２）牛血清白蛋白耦联皮质酮（Ｂ－ＢＳＡ）对ＡＶＰ的释放具有快速的（２０ｍｉｎ）抑制性效应,在１０￣（－７）─１０￣（－４）ｍｏｌ／Ｌ范围内呈剂量一效应关系;（３）ＧＣ细胞内受体拮抗剂ＲＵ４８６（１０￣（－４）─１０￣（－３）ｍｏｌ／Ｌ）能部分地阻断Ｂ─ＢＳＡ的快速抑制效应;（４）孵育液中Ｃａ￣（２＋）程度升高,Ｂ─ＢＳＡ的快速抑制效应明显增强;反之,孵育液中无Ｃａ￣（２＋）则Ｂ－ＢＳＡ的快速抑制效应有所减弱。表明ＧＣ在未进入细胞内的情况下也可快速地抑制大鼠下丘脑薄片释放ＡＶＰ,因此没有通过传统的基因组机制,而是由非基因组机制介导的,其作用部位在细胞膜水平上,可能是影响Ｃａ￣（２＋）的跨细胞膜内流通量或／和影响有Ｃａ￣（２＋）参与的ＡＶＰ释放过程的结果。     

糖皮质激素及其他甾体激素对大鼠下丘脑薄片释放精氨酸加压素的影响

本工作采用离体孵育技术,观察大鼠下丘脑薄片（含有室旁核和视上核）释放精氨酸加压素（ＡＶＰ）和糖皮质激素（ＧＣ）及其他甾体激素对ＡＶＰ释放的快速影响。结果如下：（１）大鼠下丘脑薄片经过９０ｍｉｎ的恢复之后,在长达６ｈ的孵育过程中能够相当稳定地释放ＡＶＰ,释放量为９．０６±１．２３ｐｇ／ｍｉｎ;（２）皮质酮（Ｂ）在２０ｍｉｎ内可明显地抑制ＡＶＰ的释放,在１０－７—１０－４ｍｏｌ／Ｌ范围内呈剂量－效应关系;（３）在同一剂量（１０－６ｍｏｌ／Ｌ）,皮质醇、１７β－雌二醇和睾丸酮也可快速地抑制ＡＶＰ的释放,而相同剂量的地塞米松、醛固酮、孕酮、ＲＵ４８６和胆固醇却无此效应;（４）ＲＵ４８６（１０－７—１０－３ｍｏｌ／Ｌ）对ＡＶＰ的释放没有影响,但却能（１０－５—１０－３ｍｏｌ／Ｌ）部分地阻断Ｂ的快速抑制效应。这些结果表明,ＧＣ对大鼠下丘脑ＡＶＰ的释放具有不通过传统的基因组机制的快速抑制效应,此种抑制效应可能与ＧＣ的负反馈调节作用有关。     

皮质酮在体外快速抑制精氨酸加压素释放的机制

本实验采用离体孵育脑薄片技术,初步探讨了皮质酮快速抑制大鼠下丘脑薄片释放精氨酸加压素（ＡＶＰ）的机制。结果表明：（１）放线菌素Ｄ（基因转录抑制剂）、嘌呤霉素（蛋白质合成抑制剂）和秋水仙碱（轴浆运输阻滞剂）均不影响皮质酮的快速抑制效应;（２）提高孵育液Ｃａ￣(２＋)浓度,ＡＶＰ释放增加,皮质酮的快速抑制效应明显增强;反之,孵育液中无Ｃａ￣(２＋)则ＡＶＰ释放减少,皮质酮的快速抑制效应也减弱;（３）新霉素（抑制细胞膜磷酸肌醇水解）使皮质酮的快速抑制效应增强。（４）氨茶碱（磷酸二酯酶抑制剂）不影响皮质酮的快速抑制效应。提示,皮质酮对大鼠下丘脑薄片释放ＡＶＰ的快速抑制效应没有通过传统的基因组机制,而由非基因纽机制介导,推测可能是影响Ｃａ￣(２＋)的跨细胞膜流动或／和细胞内Ｃａ￣(２＋)释放的结果。     

P物质对GABAA和GABAB受体介导的DRG神经元膜反应的调制作用

实验在幼年大鼠ＤＲＧ标本上进行。应用细胞内记录观察了ＳＰ对ＧＡＢＡ反应的调制作用。结果证明：（１）单独滴加ＳＰ（５×１０（－６）－４×１０（－５）ｍｏｌ／Ｌ）或浴槽灌流ＳＰ（１０（－６）－５×１０（－６）ｍｏｌ／Ｌ）不引起膜电位的改变或仅有轻微的去极化,但却能使ＧＡＢＡ引起的去极化反应减小５０．８±２０．２％（±ＳＤ）（２０／３０）;（２）单独滴加ＳＰ可使多数受检细胞ＡＰＤ５０延长２８．７±９．１％（±ＳＤ）（１０／１８）;（３）在预加ＳＰ后,能使ｂａｃｌｏｆｅｎ所引起的ＡＰＤ５０缩短效应（２０．６±２．９％,±ＳＤ）完全消除（４／１２）或翻转成ＡＰＤ（５０）延长１９．３±８．９％（±ＳＤ）（８／１２）;（４）预加ＧＡＢＡＢ受体激动剂ｂａｃｌｏｆｅｎ（１０（－４）－１０（－３）ｍｏｌ／Ｌ）３０—９０ｓ后明显地抑制ｍｕｓｃｉｍｏｌ（１０－４－１０－３ｍｏｌ／Ｌ）引起的去极化反应,其抑制效应达５４．４±１８．８％（±ＳＤ）（１７／２０）。由于ＤＲＧ神经元的胞体通常可用来作为研究初级传入终末的模型,因而本文实验结果提示：介导伤害性刺激信息的Ｐ物质在背角的释放,可能作用于初级传入终末,从而产生对抗ＧＡＢＡ介导的突触     

P物质对大鼠DRG神经元胞体膜的作用

本文在大鼠ＤＲＧ神经元标本上应用细胞内记录,以确定ＳＰ对ＤＲＧ细胞的膜反应及其可能的离子机制。实验所测ＤＲＧ细胞静息膜电位为－５８．９±８．２ｍＶ（Ｘ±ＳＥ,ｎ＝８１）。传导速度：Ａ_（α／β）细胞为２０．４±４．８ｍ／ｓ（Ｘ±ＳＥ）,范围１４．１－２８．７ｍ／ｓ（４７／６０）;Ａδ及Ｃ类细胞为９．８±５．２ｍ／ｓ,范围１．２－１３．７ｍ／ｓ（１３／６０）。浴槽滴加ＳＰ（１０￣（－７）－３×１０￣（－４）ｍｏｌ／Ｌ）在大多数细胞可引起明显的膜去极化反应（５６／６０）。少数细胞对ＳＰ无反应（４／６０）。在ＳＰ去极化期间膜电导值有所增加,从平均值２．７２×１０￣（－８）ｍｈｏ增加２４．６％（ｎ＝３）。所测逆转电位值在＋４０－＋５０ｍＶ之间（ｎ＝３）。浊流平衡液（ＢＳＳ）中ＮａＣｌ以氯化胆碱置代,或用含ＴＴＸ（１０￣（－５）ｍｏｌ／Ｌ）的ＢＳＳ灌流,可使ＳＰ－去极化幅值大大减小但不能完全消除。而高（２０ｍｍｏｌ／Ｌ）和低（０ｍｍｏｌ／Ｌ）Ｃａ￣（２＋）的ＢＳＳ灌流时,使ＳＰ－去极化幅值相应的增加和降低。用含１０￣（－４）ｍｏｌ／ＬＣｄ￣（２＋）及１０￣（－２）ｍｏｌ／ＬＴＥＡ的ＢＳＳ灌流,均使ＳＰ－去极化明显减小。     

P物质对大鼠分离的DRG细胞GABA激活电流的抑制作用

本文就用全细胞膜片箝技术,在新鲜分离的大鼠ＤＲＧ细胞上证明,在部分细胞Ｐ物质（１０＾－７－１０＾－５ｍｏｌ／Ｌ）可引起浓度依赖性的内向流（４／２６）;在多数细胞虽未检测到ＳＰ引起的膜电流,但却能对ＧＡＢＡＡ受体激活介导的膜内向流产生抑制效应（１８／２２）,并有加速去敏感的作用。本文就有关ＳＰ以ＧＡＢＡ激活电流抑制效应的可能意义进行了讨论。     

高血压大鼠红细胞膜Ca^2＋,Mg^2＋—ATP酶对Ca^2＋反应的变...

本实验观察了正常及高血压大鼠红细胞膜Ｃａ＾２＋,Ｍｇ＾２＋－ＡＴＰ酶对不同浓度Ｃｕ＾２＋Ｍｇ＾２＋的反应。结果表明：（１）在自发性高血压大鼠（ＳＨＲ）,此酶最适反应的Ｃａ＾２＋浓度为１０＾－６ｍｏｌ／Ｌ;ＷＫＹ大鼠为１０＾－４ｍｏｌ／Ｌ;两肾一环型肾性高血压大鼠（ＲＨＲ）为１０＾－７ｍｏｌｇ／Ｌ,Ｗｉｓｔａｒ大鼠为１０＾－４ｍｏｌ／Ｌ;Ｃａ＾２＋高于以上各相应浓度时该酶活性受到抑制;（２）作为该酶     

SNP抑制5-HT诱导的胞内游离钙浓度升高和内钙释放

用Ｆｕｒａ － ２／ＡＭ 荧光测量技术研究了５ － 羟色胺（５－ ＨＴ） 诱导的大鼠尾动脉平滑肌细胞胞内钙升高和一氧化氮（ＮＯ） 的抑制效应。实验表明, 胞外０ｍ ｍｏｌ／ Ｌ Ｃａ２ ＋ 时胞内静息［Ｃａ２ ＋ ］ ｉ 为２０ ．２±８ ．６ｎｍｏｌ／Ｌ（ｎ ＝ ８） 。１０μｍｏｌ／Ｌ ５－ ＨＴ 可诱导出胞内钙库释放引起的瞬态［Ｃａ２ ＋］ｉ 升高,其峰值达２４５ ．７ ±７１．６ｎｍｏｌ／ Ｌ（ｎ ＝ ６） 。１０ － ７ ｍｏｌ／Ｌ 硝普钠（ＳＮＰ） 可抑制５－ ＨＴ 诱导的［Ｃａ２ ＋］ｉ 升高,其峰值浓度降为７５．１±３５ ．９ｎｍｏｌ／Ｌ（ｎ ＝ ５） 。当细胞浴液含２．５ｍ ｍｏｌ／Ｌ Ｃａ２ ＋ 时,静息［Ｃａ２ ＋］ｉ为１１２ ．８ ±１０ ．３ｎｍｏｌ／ Ｌ（ｎ ＝ ５） , 这时１０μｍｏｌ／ Ｌ ５ － ＨＴ 可诱导［Ｃａ２ ＋ ］ ｉ 的峰值为２５２ ．３ ±８０ ．６ｎｍｏｌ／Ｌ（ｎ ＝ ４） ,以及其后平台浓度为１４３ ．０ ±３７ ．６ｎｍｏｌ／Ｌ（ｎ ＝ ４） ,略大于［Ｃａ２ ＋］ｉ 为１１２．８ ±１０ ．３ｎｍｏｌ／Ｌ 的静息浓度,为外钙内流引起。１０ － ７ ｍｏｌ／Ｌ ＳＮＰ 也可抑制５－ ＨＴ 诱导［Ｃａ２ ＋ ］ｉ 平台相浓度。平台浓度由１４３ ±４７     

17β-雌二醇诱导血管内皮细胞一氧化氮释放及其与细胞内钙的关系

利用小牛胸主动脉内皮细胞（ＢＡＥＣｓ）作为模型,观察１７β－雌二醇（Ｅ２）ＢＡＥＣｓ一氧化氮（ＮＯ）释放、一氧化氮合酶（ｅＮＯＳ）ｍＲＮＡ表达和细胞内钙（〔Ｃａ＾２＋〕ｉ）的影响,以及雌激素受体（ＥＲ）拮抗剂ｔａｍｏｘｉｆｅｎ和ＮＯＳ抑制剂（Ｌ－ＮＡＭＥ）的作用。结果显示,Ｅ２（１０＾－１２￣１０＾－８ｍｏｌ／Ｌ）呈尝试依赖性促进ＢＡＥＣｓ中ＮＯ的释放,以１０＾－８ｍｏｌ／Ｌ浓度Ｅ２处理ＢＡＥＣｓ     

高血压大鼠红细胞膜Ca~（2＋），Mg~（2＋）─ATP酶对Ca~（2＋）反应的变化及Mg~（2＋）的作用

本实验观察了正常及高血压大鼠红细胞膜Ｃａ２＋,Ｍｇ２＋－ＡＴＰ酶对不同浓度Ｃａ２＋及Ｍｇ２＋的反应。结果表明：（１）在自发性高血压大鼠（ＳＨＲ）,此酶最适反应的Ｃａ２＋浓度为１０－６ｍｏｌ／Ｌ;ＷＫＹ大鼠为１０－４ｍｏｌ／Ｌ;两肾一环型肾性高血压大鼠（ＲＨＲ）为１０－７ｍｏｌ／Ｌ,Ｗｉｓｔａｒ大鼠为１０－４ｍｏｌ／Ｌ,Ｃａ２＋高于以上各相应浓度时该酶活性受到抑制;（２）作为该酶激动剂的Ｍｇ２＋有其最适激活浓度,在ＷＫＹ大鼠、ＲＨＲ及Ｗｉｓｔａｒ大鼠均为４．５ｍｏｌ／Ｌ;（３）高浓度Ｍｇ２＋（３６．０ｍｏｌ／Ｌ）可以逆转高浓度Ｃａ２＋对该酶的抑制作用。以上结果表明,底物Ｃａ２＋浓度的变化对Ｃａ２＋,Ｍｇ２＋－ＡＴＰ酶的催化活性影响极大,该酶活性的促发及维持必须有适宜浓度的Ｍｇ２＋。高血压时此酶对Ｃａ２＋的敏感性增高,且Ｍｇ２＋对酶保护作用更为明显。本结果提示,胞内高浓度Ｃａ２＋不仅是高血压发生的原因之一,并可能与其发展及恶化有关。     

外源Ca^2＋对烟草花粉管生长和生殖核分裂的调节

用细胞学和统计学方法研究了外源Ca~(2 )对烟草(Nicotiana tabacum L.)离体花粉管生长和生殖核分裂的影响。正常培养条件下,花粉管群体内的生殖核分裂率大致呈对数增长,10～18h为其分裂高峰期。所用Ca~(2 )浓度中以10~(-3)mol/L最适于花粉管生长,与之相比,其它浓度随时间延长愈益明显地表现出抑制效应。生殖核分裂则以10~(-2)与10~(-3)mol/L较为适宜,且10~(-2)mol/L可相对提前分裂高峰。在含10~(-3)mol/L Ca~(2 )培养基中培养10h后用不同方法处理,发现高钙抑制花粉管生长,尤以10~(-1)mol/L Ca~(2 )抑制最强烈,导致花粉管顶端壁加厚及生殖核的无丝分裂。而10~(-2)mol/L Ca~(2 )在处理早期(10～12h)促进生殖核分裂。EGTA处理则同时抑制花粉管生长和生殖核分裂。     

Exogenous Ca2+ Regulation of Pollen Tube Growth and Division of Generative Nucleus in Nicotiana tabacum

Cytological and statistical studies on the effects of exogenous Ca2 + on in vitro pollen tube growth and generative nucleus (GN) division of tobacco (Nicotiana tabacum L. ) were conducted in an artificial experimental system. Under normal cultured conditions, the rate of GN division increased logarithmically in general, and reaches the climax at about 10 - 18 h. Among the treatments with various Ca2 + concentrations, 10- 3 mol/L was the optimal concentration for pollen tube growth, whereas other Ca2+ concentrations showed increasing inhibitory effect with the time of culture. Generally, Ca2 + concentrations at 10-2 and 10-3 mol/L favored GN division more than the others. Compared with 10-3 mol/L Ca2 + concentration at 10-2 mol/L benefitiated GN division at earlier stage of the treatment, but afterwards showed inhibitory effect gradually. Besides, the authors designed another series of experiments, in which 10-2, 10-1 mol/L Ca2+ (final concentrations) or 2,10 mmol/L EG-TA was respectively added to the medium containing 10-3 mol/L Ca2+ at 10 h of culture. Pollen tube growth was inhibited by the high Ca2+ treatments, especially being severely effected by 10-l mol/L Ca2 + from which wall, thickening of the tube tip, amitotic division of GN leading to micronucleus formation occurred. 10-2 mol/L Ca2 + treatment, however, promoted GN division at the earlier stage of treatment ( 10 - 12 h). EGTA treatments inhibited both pollen tube growth and GN division.     

Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.

Ghrelin and synthetic growth hormone secretagogues have diverse effects on the hypothalamus including effects on appetite and the growth hormone axis as well as on the hypothalamus-pituitary-adrenal (HPA) axis. We previously studied the effect of synthetic growth hormone secretagogues on CRH and AVP release from rat hypothalami in vitro, and now report on the effects of ghrelin on CRH and AVP release. The ghrelin protein content and ghrelin output from rat hypothalamic explants was measured using a specific novel ghrelin enzyme immunoassay. The effect of 10(-8) M to 10(-6) M ghrelin on CRH and AVP release was studied in the rat hypothalamic explants, where stimulation with des-octanoyl ghrelin was used as control. The presence of both ghrelin mRNA and protein could be shown in the rat hypothalamus. Ghrelin output was detected in the incubation fluid of rat hypothalamic explants and could be stimulated with high potassium concentrations. Our data also demonstrated a dose-dependent effect of ghrelin on both CRH and AVP release, while des-octanoylated ghrelin showed no effect on either peptide. In summary, the current data suggest that ghrelin is expressed in the hypothalamus both at RNA and the protein levels. Ghrelin stimulates the HPA axis in the rat via stimulation of both CRH, and particularly, AVP release from the hypothalamus. The local autocrine/paracrine and endocrine effects of ghrelin in the hypothalamus could influence all the hormonal systems involved in ghrelin effects, including growth hormone release, the HPA axis and appetite.     

Effect of synthetic atrial natriuretic factor on arginine vasopressin release by the rat hypothalamo-neurohypophysial complex in organ culture

The effect of synthetic rat atrial natriuretic factor (ANF, Arg 101-Tyr 126) was evaluated in an in-vitro model of rat hypothalamo-neurohypophysial complex (HNC) in organ culture in which part of hypothalamus containing a portion of undamaged magnocellular neurons is separated from posterior pituitary by a fluid tight barrier with an intact stalk connecting both structures. ANF, when added to the medium at the hypothalamus site at concentrations of 3 X 10(-5) M to 3 X 10(-7) M, did not change basal AVP release from the posterior pituitary. Similarly, a shorter form of ANF (Cys 105-Tyr 126), reported to be highly potent in inhibiting adenylate cyclase activity in various tissues, exerted no effect on AVP excretion from HNC in organ culture. The application of an hyperosomotic medium (osmolality 324 +/- 2 mOsm/kg H2O) to the hypothalamic side, together with ANF (3 X 10(-6) M), significantly lowered osmotically-stimulated AVP release. It is concluded that ANF has no effect on basal AVP release from HNC in culture and suppresses osmotically-stimulated AVP secretion in this in vitro model.     

Characterization of the inositol 1,4,5-trisphosphate-induced calcium release from permeabilized endocrine cells and its inhibition by decavanadate and p-hydroxymercuribenzoate.

The inositol 1,4,5-trisphosphate (IP3)-sensitive Ca2+ compartment of endocrine cells was studied with alpha-toxin- and digitonin-permeabilized rat insulinoma (RINA2) and rat pheochromocytoma (PC12) cells. The Ca2+ uptake was ATP-dependent, and submicromolar concentrations of IP3 specifically released the stored Ca2+. Half-maximal Ca2+ release was observed with 0.25-0.5 mumol of IP3/l, and the amount of Ca2+ released due to IP3 could be enhanced by additional loading of the Ca2+ compartment. Consecutive additions of the same concentration of IP3 for 1-2 h always released the same amount of Ca2+ without desensitization, providing an ideal basis to further characterize the IP3-induced Ca2+ release. Here we describe for the first time a reversible inhibitory effect of decavanadate on the IP3-induced Ca2+ release. Among the vanadium species tested (decavanadate, oligovanadate and monovanadate), only decavanadate was inhibitory, with a half-maximal effect at 5 mumol/l in both cell types. The effect of decavanadate could be overcome by increasing the amount of sequestered Ca2+ or added IP3. Decavanadate did not affect the ATP-driven Ca2+ uptake but oligovanadate was inhibitory on Ca2+ uptake. p-Hydroxymercuribenzoate (pHMB) at concentrations between 10 and 30 mumol/l also inhibited the Ca2+ release due to IP3. Thiol compounds such as dithiothreitol (DTT; 1 mmol/l) added before pHMB removed all its inhibitory effect on the IP3-induced Ca2+ release, whereas the inhibition caused by decavanadate was unaffected by DTT. Thus, the decavanadate-dependent inhibition functions by a distinctly different mechanism than pHMB and could serve as a specific tool to analyse various aspects of the IP3-induced Ca2+ release within endocrine cells.     

糖皮质激素对大鼠肾上腺髓质嗜铬细胞瘤细胞ACh诱发电流的快速抑制作用

本研究采用全细胞膜片箝 技术,以大鼠肾上腺髓质嗜铬细胞瘤细胞为标本,观察了糖皮质激素对乙胆碱诱发电流的快速作用,并初步探讨了其可能机制。     

Role of Adenylate Cyclase in Presynaptic α2-Adrenoceptor- and μ-Opioid Receptor-Mediated Inhibition of [3H]Noradrenaline Release from Rat Brain Cortex Slices

Rat brain cortex slices, prelabelled with [3H]noradrenaline, were superfused and exposed to electrical biphasic block pulses (1 Hz; 12 mA, 4 ms) or to the Ca2+ ionophore A 23187 (10 microM) in the presence of 1.2 mM Ca2+. Forskolin (10 microM), 8-bromo-cyclic AMP (300 microM), and dibutyryl-cyclic AMP (300 microM) facilitated both the electrically evoked and A 23187-induced [3H]noradrenaline release, whereas the phosphodiesterase inhibitors 3-isobutyl-1-methylxanthine (IBMX, 300 microM) and 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62771, 30 microM) enhanced the electrically evoked release only. The inhibitory effects of clonidine (1 nM-1 microM) and the facilitatory effect of phentolamine (0.01-10 microM) on the electrically evoked [3H]noradrenaline release were strongly reduced in the presence of 8-bromo-cyclic AMP. Clonidine (1 microM) reduced and phentolamine (3 microM) enhanced A 23187-induced [3H]noradrenaline release, provided that the slices were simultaneously exposed to forskolin. The inhibitory effects of morphine (1 microM) and [D-Ala2-D-Leu5]enkephalin (DADLE, 0.3 microM), like that of the Ca2+ antagonist Cd2+ (15 microM), on the electrically evoked release of [3H]noradrenaline were not affected by 8-bromo-cyclic AMP. Moreover, morphine and DADLE did not inhibit A 23187-induced release in the absence or presence of forskolin. These data strongly suggest that in contrast to presynaptic mu-opioid receptors, alpha 2-adrenoceptors on noradrenergic nerve terminals are negatively coupled to adenylate cyclase and may thus reduce neurotransmitter release by inhibiting the feed-forward action of cyclic AMP on the secretion process.     

Nitric Oxide-Induced Release of Acetylcholine in the Nucleus Accumbens: Role of Cyclic GMP, Glutamate, and GABA

Abstract: We have previously shown that the basal acetylcholine release in the ventral striatum is under the enhancing influence of endogenous nitric oxide (NO) and that NO donors cause pronounced increases in the acetylcholine release rate. To investigate the role of cyclic GMP, glutamate, and GABA in the NO-induced acetylcholine release, we superfused the nucleus accumbens, (Nac) of the anesthetized rat with various compounds through a push-pull cannula and determined the neurotransmitter released in the perfusate. Superfusion of the Nac with the NO donors diethylamine/NO (DEANO; 100 µmol/L), S-nitroso-N-acetylpenicillamine (SNAP; 200 µmol/L), or 3-morpholinosydnonimine (SIN-1; 200 µmol/L) enhanced the acetylcholine release rate. The guanylyl cyclase inhibitor 1H-(1,2,4)-oxodiazolo(4,3-a)quinoxalin-1-one (ODQ; 10 µmol/L) abolished the effects of DEANO and SIN-1. 6-(Phenylamino)-5,8-quinolinedione (LY-83583; 100 µmol/L), which also inhibits cyclic GMP synthesis, inhibited the releasing effects of DEANO and of SNAP, whereas the effect of SIN-1 on acetylcholine release was not influenced. The DEANO-induced release of acetylcholine was also abolished in the presence of 20 µmol/L 6,6-dinitroquinoxaline-2,3-dione (DNQX) and 10 µmol/L (±)-2-amino-5-phosphonopentanoic acid (AP-5). Simultaneous superfusion with 50 µmol/L quinpirole and 10 µmol/L 7-bromo-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SKF 83566) was ineffective. Superfusion with 500 µmol/L DEANO decreased the release of acetylcholine. The inhibitory effect of 500 µmol/L DEANO was reversed to an enhanced release on superfusion with 20 µmol/L bicuculline. Bicuculline also enhanced the basal release rate. These findings indicate that cyclic GMP mediates the NO-induced release of acetylcholine by enhancing the outflow of glutamate. Dopamine is not involved in this process. Only high concentrations of NO increase the output of GABA, which in turn decreases acetylcholine release. Our results suggest that cells that are able to release glutamate, such as glutamatergic neurons, are the main target of NO in the Nac.     

虎纹蛙促性腺激素释放激素分泌调节的离体研究

利用离体静态孵育系统和放射免疫测定法,研究了性成熟的虎纹蛙雌蛙离体的视前－下丘脑－正中隆起（P－H－ME）片段促性腺激素释放激素（GnRH)的分泌调节。结果表明：γ－氨基丁酸（GABA）对成熟前期蛙离体P－H－ME片段的哺乳类GnRH（mGnRH)的释放有显著的刺激作用;随着GABA作用浓度的增加,刺激作用逐渐增强。100μmol/L的多巴胺（DA）及1μmol/L和10μmol/L的雌二醇(E2）则显著抑制鸡ⅡGnRH(cGnRH-Ⅱ)的释放。10μmol/L和100μmol/L的睾酮（T）以及10μmol/L的E2显著刺激冬眠期蛙P－H－ME片段mGnRH的释放。这些结果表明,GABA,DA及E2和T对虎蚊蛙GnRH的释放有直接的调节作用。